Skip to content

144Accepted May 26, 7:00 AM ET

EyePoint Pharmaceuticals, Inc. 144

Ocumension Therapeutics

Accepted (ET)

7:00 AM

May 26, 2023

Filed

May 26, 2023

Documents

1

Size

4.9 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.